SB 1219 - Under this act, any entity registered with the Department of Health and Senior Services that possesses, distributes, or delivers hypodermic needles or syringes for the purposes of operating a syringe exchange program or otherwise mitigating health risks associated with unsterile injection drug use shall be exempt from the offense of unlawful distribution, delivery, or sale of drug paraphernalia, if such entity is not located within 500 feet of a school building, as well as the offense of unlawful manufacturing with intent to deliver drug paraphernalia. This act is identical to SB 472 (2025), SB 997 (2024), SB 623 (2023), provisions in CCS/HCS/SS/SB 690 (2022), and CCS#2/HCS/SS/SB 64 (2021), substantially similar to HB 1486 (2020), SB 668 (2020), HCS/SS/SB 580 (2020), and HCS/HB 168 (2019), and similar to SCS/HB 1620 (2019). SARAH HASKINS

2026 Regular Session Introduced by Patty Lewis

SB 1219 modifies Missouri's hypodermic needle distribution regulations, affecting access to sterile injection equipment and related public health policy.

Second Read and Referred S Families, Seniors and Health Committee

Legislative bill overview

SB 1219 modifies Missouri's regulations governing the distribution of hypodermic needles, likely addressing needle exchange programs or access to sterile injection equipment. The bill is currently in early legislative stages and has been referred to the Senate Families, Seniors and Health Committee for review.

Why is this important

Needle distribution policies directly affect public health outcomes related to infectious disease transmission (HIV, hepatitis C) among people who use drugs, while also raising questions about drug use enablement. Missouri's approach to this issue influences healthcare costs, criminal justice priorities, and harm reduction philosophy in the state.

Potential points of contention

Harm reduction vs. drug policy philosophy: Disagreement over whether needle access reduces disease without encouraging drug use, or whether it enables drug consumption

Local implementation authority: Questions about whether cities/counties should set their own needle distribution rules or if state-level uniformity is required

Funding and regulatory scope: Debate over which entities (nonprofits, pharmacies, health departments) can distribute needles and who bears the cost

Public safety concerns: Disputes about needle disposal infrastructure and community safety in areas with distribution programs